STOCK TITAN

Replimune director proposes $694K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Replimune Group, Inc. (REPL) director Veleka Peeples-Dyer reported 34,500 common shares for sale, with an approximate sale date of November 17, 2026, and an aggregate market value of $693,544.50. She acquired those shares from the issuer through a stock option exercise paid in cash on November 17, 2026.

Shares reported for sale 34,500 shares Replimune common shares; approximate sale date November 17, 2026
Aggregate market value $693,544.50 Shares reported for sale
Shares outstanding 94,800,404 shares Reported on Form 144
Prior sale 10,000 shares; $167,232.00 gross proceeds October 30, 2026
Prior sale 12,000 shares; $154,744.80 gross proceeds October 28, 2026
Stock Option Exercise financial
"Nature of Acquisition Transaction: Stock Option Exercise"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many REPL shares did director Veleka Peeples-Dyer report for sale?

Veleka Peeples-Dyer reported 34,500 common shares for sale, with an approximate sale date of November 17, 2026, and an aggregate market value of $693,544.50.

What REPL shares did Veleka Peeples-Dyer sell in the prior three months?

Her prior reported sales were 10,000 shares on October 30, 2026, for gross proceeds of $167,232.00, and 12,000 shares on October 28, 2026, for gross proceeds of $154,744.80.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading